Cargando…

The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned

AIM: To develop and evaluate the comparative effectiveness of behavioural interventions of enhanced prevention counselling (EPC) and simple educational counselling (SEC) in reducing hepatitis C viral (HCV) infection in sero-negative injecting drug users (IDU). DESIGN: Randomised controlled trial (RC...

Descripción completa

Detalles Bibliográficos
Autores principales: Abou-Saleh, Mohammed, Davis, Paul, Rice, Philip, Checinski, Ken, Drummond, Colin, Maxwell, Douglas, Godfrey, Christine, John, Christopher, Corrin, Betsy, Tibbs, Christopher, Oyefeso, Adenekan, de Ruiter, Marian, Ghodse, Hamid
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2531167/
https://www.ncbi.nlm.nih.gov/pubmed/18671853
http://dx.doi.org/10.1186/1477-7517-5-25
_version_ 1782158974968135680
author Abou-Saleh, Mohammed
Davis, Paul
Rice, Philip
Checinski, Ken
Drummond, Colin
Maxwell, Douglas
Godfrey, Christine
John, Christopher
Corrin, Betsy
Tibbs, Christopher
Oyefeso, Adenekan
de Ruiter, Marian
Ghodse, Hamid
author_facet Abou-Saleh, Mohammed
Davis, Paul
Rice, Philip
Checinski, Ken
Drummond, Colin
Maxwell, Douglas
Godfrey, Christine
John, Christopher
Corrin, Betsy
Tibbs, Christopher
Oyefeso, Adenekan
de Ruiter, Marian
Ghodse, Hamid
author_sort Abou-Saleh, Mohammed
collection PubMed
description AIM: To develop and evaluate the comparative effectiveness of behavioural interventions of enhanced prevention counselling (EPC) and simple educational counselling (SEC) in reducing hepatitis C viral (HCV) infection in sero-negative injecting drug users (IDU). DESIGN: Randomised controlled trial (RCT) of EPC intervention in comparison with simple educational counselling (SEC). SETTING SPECIALISED: Drug services in London and Surrey, United Kingdom. PARTICIPANTS AND MEASUREMENTS: Ninety five IDUs were recruited and randomised to receive EPC (n = 43) or SEC (n = 52). Subjects were assessed at baseline using the Addiction Severity Index (ASI), the Injecting Risk Questionnaire (IRQ), and Drug Injecting Confidence Questionnaire (DICQ). The primary outcome was measured by the rate of sero-conversion at 6 months and 12 months from baseline and by the ASI, IRQ and DICQ at 6 months from baseline. Hepatitis C testing was undertaken by the innovative test of the dried blood spot (DBS) test which increased the rate of testing by 4 fold compared to routine blood testing. FINDINGS SEVENTY: Eighty two subjects (82%) out of the 95 recruited were followed up at 6 months and 62 (65%) were followed up at 12 months. On the primary outcome measure of the rate of seroconversion, 8 out of 62 patients followed-up at twelve months seroconverted, three in the EPC group and five in the SEC group, indicating incidence rates of 9.1 per 100 person years for the EPC group, 17.2 per 100 person years for the SEC group, and 12.9 per 100 person years for the cohort as a whole. Analysis of the secondary outcome measures on alcohol use, risk behaviour, psychological measures, quality of life, showed no significant differences between the EPC and the SEC groups. However, there were significant changes on a number of measures from baseline values indicating positive change for both groups. CONCLUSION: We were not able to prove the efficacy of EPC in comparison with SEC in the prevention of hepatitis C in IDUs. This was related to low recruitment and retention rates of the participants. Moreover there was a low adherence rate to EPC. The study provided the benefits of developing and introducing behavioural interventions of the EPC and SEC and the DBS screening for Hepatitis C. Moreover the main lessons learnt were that piloting of a new intervention is a crucial first step before conducting pragmatic RCTs of psychological interventions in the field of addiction; that an infrastructure and culture for psychosocial interventions is needed to enable applied research in the service environment, and research funding is needed for enabling the recruitment of dedicated trained therapists for the delivery of these interventions.
format Text
id pubmed-2531167
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25311672008-09-07 The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned Abou-Saleh, Mohammed Davis, Paul Rice, Philip Checinski, Ken Drummond, Colin Maxwell, Douglas Godfrey, Christine John, Christopher Corrin, Betsy Tibbs, Christopher Oyefeso, Adenekan de Ruiter, Marian Ghodse, Hamid Harm Reduct J Research AIM: To develop and evaluate the comparative effectiveness of behavioural interventions of enhanced prevention counselling (EPC) and simple educational counselling (SEC) in reducing hepatitis C viral (HCV) infection in sero-negative injecting drug users (IDU). DESIGN: Randomised controlled trial (RCT) of EPC intervention in comparison with simple educational counselling (SEC). SETTING SPECIALISED: Drug services in London and Surrey, United Kingdom. PARTICIPANTS AND MEASUREMENTS: Ninety five IDUs were recruited and randomised to receive EPC (n = 43) or SEC (n = 52). Subjects were assessed at baseline using the Addiction Severity Index (ASI), the Injecting Risk Questionnaire (IRQ), and Drug Injecting Confidence Questionnaire (DICQ). The primary outcome was measured by the rate of sero-conversion at 6 months and 12 months from baseline and by the ASI, IRQ and DICQ at 6 months from baseline. Hepatitis C testing was undertaken by the innovative test of the dried blood spot (DBS) test which increased the rate of testing by 4 fold compared to routine blood testing. FINDINGS SEVENTY: Eighty two subjects (82%) out of the 95 recruited were followed up at 6 months and 62 (65%) were followed up at 12 months. On the primary outcome measure of the rate of seroconversion, 8 out of 62 patients followed-up at twelve months seroconverted, three in the EPC group and five in the SEC group, indicating incidence rates of 9.1 per 100 person years for the EPC group, 17.2 per 100 person years for the SEC group, and 12.9 per 100 person years for the cohort as a whole. Analysis of the secondary outcome measures on alcohol use, risk behaviour, psychological measures, quality of life, showed no significant differences between the EPC and the SEC groups. However, there were significant changes on a number of measures from baseline values indicating positive change for both groups. CONCLUSION: We were not able to prove the efficacy of EPC in comparison with SEC in the prevention of hepatitis C in IDUs. This was related to low recruitment and retention rates of the participants. Moreover there was a low adherence rate to EPC. The study provided the benefits of developing and introducing behavioural interventions of the EPC and SEC and the DBS screening for Hepatitis C. Moreover the main lessons learnt were that piloting of a new intervention is a crucial first step before conducting pragmatic RCTs of psychological interventions in the field of addiction; that an infrastructure and culture for psychosocial interventions is needed to enable applied research in the service environment, and research funding is needed for enabling the recruitment of dedicated trained therapists for the delivery of these interventions. BioMed Central 2008-07-31 /pmc/articles/PMC2531167/ /pubmed/18671853 http://dx.doi.org/10.1186/1477-7517-5-25 Text en Copyright © 2008 Abou-Saleh et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Abou-Saleh, Mohammed
Davis, Paul
Rice, Philip
Checinski, Ken
Drummond, Colin
Maxwell, Douglas
Godfrey, Christine
John, Christopher
Corrin, Betsy
Tibbs, Christopher
Oyefeso, Adenekan
de Ruiter, Marian
Ghodse, Hamid
The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned
title The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned
title_full The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned
title_fullStr The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned
title_full_unstemmed The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned
title_short The effectiveness of behavioural interventions in the primary prevention of Hepatitis C amongst injecting drug users: a randomised controlled trial and lessons learned
title_sort effectiveness of behavioural interventions in the primary prevention of hepatitis c amongst injecting drug users: a randomised controlled trial and lessons learned
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2531167/
https://www.ncbi.nlm.nih.gov/pubmed/18671853
http://dx.doi.org/10.1186/1477-7517-5-25
work_keys_str_mv AT abousalehmohammed theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT davispaul theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT ricephilip theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT checinskiken theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT drummondcolin theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT maxwelldouglas theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT godfreychristine theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT johnchristopher theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT corrinbetsy theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT tibbschristopher theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT oyefesoadenekan theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT deruitermarian theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT ghodsehamid theeffectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT abousalehmohammed effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT davispaul effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT ricephilip effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT checinskiken effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT drummondcolin effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT maxwelldouglas effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT godfreychristine effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT johnchristopher effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT corrinbetsy effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT tibbschristopher effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT oyefesoadenekan effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT deruitermarian effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned
AT ghodsehamid effectivenessofbehaviouralinterventionsintheprimarypreventionofhepatitiscamongstinjectingdrugusersarandomisedcontrolledtrialandlessonslearned